epigallocatechin gallate has been researched along with Intervertebral Disc Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferguson, SJ; Hausmann, O; Klasen, J; Konno, S; Krupkova, O; Sekiguchi, M; Wuertz-Kozak, K | 1 |
1 other study(ies) available for epigallocatechin gallate and Intervertebral Disc Degeneration
Article | Year |
---|---|
Epigallocatechin 3-gallate suppresses interleukin-1β-induced inflammatory responses in intervertebral disc cells in vitro and reduces radiculopathic pain in rats.
Topics: Adult; Animals; Catechin; Cells, Cultured; Female; Humans; Imidazoles; Inflammation; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Intervertebral Disc; Intervertebral Disc Degeneration; Male; MAP Kinase Kinase 4; Matrix Metalloproteinases; Middle Aged; Neuralgia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Radiculopathy; Rats; Rats, Sprague-Dawley | 2014 |